Oral Mucositis: Addressing the Causes, Challenges, and Clinical Management
Carrie F. Daly, MS, RN, AOCN®, and Annette M. Quinn, MSN, RN
From Rush University Medical Center, Chicago, Illinois, and University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Carrie F. Daly, MS, RN, AOCN®, reported a financial interest/relationship or affiliation in the form of: Speakers’ Bureau, Roche Laboratories, Inc. Annette M. Quinn, MSN, RN, has no real or apparent conflicts of interest to report.
Correspondence to: Carrie F. Daly, MS, RN, AOCN®, Rush University Medical Center, Department of Radiation Oncology, Chicago, IL 60612. E-mail: firstname.lastname@example.org; Annette M. Quinn, MSN, RN, University of Pittsburgh Medical Center, Radiation Oncology, 5230 Centre Ave, Pittsburgh, PA 15232. E-mail: email@example.com
J Adv Pract Oncol 2011;2(Suppl 1):4–13 |
© 2011 Harborside Press®
Oral mucositis remains one of the most painful and debilitating side effects of cancer therapy. A working knowledge of the risk factors for oral mucositis and oral cavity assessment protocols is essential to early identification of signs and symptoms in high-risk patients. The use of evidence-based guidelines and patient education will facilitate symptom management and supportive care strategies designed to avoid reductions, delays, or discontinuation of cancer treatment.
For access to the full length article, please sign in